LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020)

LifeMD (LFMD) posted Asset Writedowns and Impairment of $74530.0 for Q4 2020, up 1728.72% on a QoQ basis from -$4576.0 in Q3 2017.

LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020) Analysis & Trends

LifeMD's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $74530.0 for Q4 2020.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $74530.0 in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $74530.0 (up 17.48% YoY) and the FY2024 annual result came in at $675669.0, up 25.66% from the prior year.
  • Asset Writedowns and Impairment was $74530.0 for Q4 2020 at LifeMD, up from -$4576.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $114694.0 in Q4 2016 and bottomed at -$38027.0 in Q1 2017.
  • A 3-year average of $28021.0 and a median of -$4576.0 in 2017 frame the typical range for Asset Writedowns and Impairment.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.68 Bn -
10 LifeMD 169.91 Mn 132.79 Mn 2.85 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 74,530.00
Dec 31, 2020 74,530.00
Sep 30, 2017 -4,576.00
Sep 30, 2017 -4,576.00
Jun 30, 2017 -6,516.00
Jun 30, 2017 -6,516.00
Mar 31, 2017 -38,027.00
Mar 31, 2017 -38,027.00
Dec 31, 2016 114,694.00
Dec 31, 2016 114,694.00